Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126693421 | 12669342 | 1 | I | 20160729 | 20160810 | 20160819 | 20160819 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52475BP | BOEHRINGER INGELHEIM | 57.62 | YR | M | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126693421 | 12669342 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 507624 | 22512 | 150 | MG | CAPSULE | BID | |||||
| 126693421 | 12669342 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 507624 | 22512 | |||||||||||
| 126693421 | 12669342 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 126693421 | 12669342 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 126693421 | 12669342 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | DOSE PER APPLICATION: 5 MG; FORMULATION: TABLET | 0 | QD | |||||||||
| 126693421 | 12669342 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 1 MG | 0 | .5 | MG | TABLET | BID | ||||||
| 126693421 | 12669342 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126693421 | 12669342 | 1 | Thrombosis prophylaxis |
| 126693421 | 12669342 | 2 | Thrombosis prophylaxis |
| 126693421 | 12669342 | 3 | Product used for unknown indication |
| 126693421 | 12669342 | 4 | Hypertension |
| 126693421 | 12669342 | 6 | Anxiety |
| 126693421 | 12669342 | 7 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126693421 | 12669342 | Abdominal distension | |
| 126693421 | 12669342 | Abdominal pain upper | |
| 126693421 | 12669342 | Dyspepsia | |
| 126693421 | 12669342 | Flatulence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126693421 | 12669342 | 1 | 20160729 | 0 | ||
| 126693421 | 12669342 | 3 | 2006 | 0 | ||
| 126693421 | 12669342 | 6 | 2009 | 0 | ||
| 126693421 | 12669342 | 7 | 2009 | 0 |